IP Library › Granted Patent US 7,803,755
Granted Patent B2
US 7,803,755 · App. 11/643,402 · Granted Sep 28, 2010

Molecules for the treatment and prevention of fungal diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,803,755
App. No.
11/643,402
Granted
Sep 28, 2010
Kind
B2
Abstract

This disclosure provides a method and a product to treat fungal nail infections and Athlete's foot in a fast and non expensive way. The product contains one or more lytic peptides in water solution.

Claims (12)

1. A method to topically treat fungal nail infections and athlete's foot, said method comprising a step of applying a solution comprising a lytic peptide selected from the group consisting of SEQ ID NOs: 1, 2, 5-13, 15, 18-31, and 33-44 on the infected nail or skin.

2. The method according to claim 1 , wherein the lytic peptide concentration of the solution is between 1 and 100 μM.

3. The method according to claim 2 , wherein the lytic peptide concentration of the solution is 75 μM.

4. The method of claim 1 , wherein the solution is applied topically on a nail three times a week.

5. A product to treat fungal nail infections and athlete's foot, said product comprising a solution comprising a lytic peptide selected from the group consisting of SEQ ID NO: 1, 2, 5-13, 15, 18-31, and 33-44.

6. The product according to claim 5 , wherein the lytic peptide concentration of the solution is between 1 and 100 μM.

7. The product according to claim 6 , wherein the lytic peptide concentration of the solution is 75 μM.

8. A kit for treating fungal nail infection and athlete's foot, said kit comprising:

a) a dry peptide preparation of a lytic peptides selected from the group consisting of SEQ ID NOs: 1, 2, 5-13, 15, 18-31, and 33-44;

b) an appropriate amount of distilled water to be mixed with the dry peptide preparation to make a solution wherein the lytic peptide concentration of the solution is between 1 and 100 μM and

c) instructions to combine peptide and water and to use the resulting solution.

9. The kit according to claim 8 , wherein the lytic peptide concentration of the solution is 75 μM.

Continuity (1)
Related Publication 20080153748A1 · Jun 26, 2008